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Caenorhabditis elegans development
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and Nathalie Pujol2*
Abstract
Background: Tribbles proteins are conserved pseudokinases that function to control kinase signalling and transcription
in diverse biological processes. Abnormal function in human Tribbles has been implicated in a number of diseases
including leukaemia, metabolic syndromes and cardiovascular diseases. Caenorhabditis elegans Tribbles NIPI-3 was
previously shown to activate host defense upon infection by promoting the conserved PMK-1/p38 mitogen-activated
protein kinase (MAPK) signalling pathway. Despite the prominent role of Tribbles proteins in many species, our
knowledge of their mechanism of action is fragmented, and the in vivo functional relevance of their interactions with
other proteins remains largely unknown.
Results: Here, by characterizing nipi-3 null mutants, we show that nipi-3 is essential for larval development and viability.
Through analyses of genetic suppressors of nipi-3 null mutant lethality, we show that NIPI-3 negatively controls
PMK-1/p38 signalling via transcriptional repression of the C/EBP transcription factor CEBP-1. We identified CEBP-1’s
transcriptional targets by ChIP-seq analyses and found them to be enriched in genes involved in development and
stress responses. Unlike its cell-autonomous role in innate immunity, NIPI-3 is required in multiple tissues to control
organismal development.
Conclusions: Together, our data uncover an unprecedented crosstalk involving multiple tissues, in which NIPI-3 acts as
a master regulator to inhibit CEBP-1 and the PMK-1/p38 MAPK pathway. In doing so, it keeps innate immunity in check
and ensures proper organismal development.
Keywords: Tribbles, C/EBP transcription factor, p38 MAP kinase, Genetic suppression, Transcriptional regulation, Signal
transduction, Development, Stress responses
Background
The Tribbles genes encode a family of highly conserved
pseudokinases which lack key catalytic amino acids in
the kinase domain [1–3]. Functional studies in multiple
organisms have shown that these pseudokinases play di-
verse roles in innate immunity, cell signalling, energy
homeostasis and cell division [2, 4]. The Drosophila tribbles
gene is required for cell proliferation and migration in em-
bryogenesis and oogenesis [5–8]. The mammalian Tribbles
family includes three genes, Trib1, Trib2 and Trib3, each of
which plays unique roles in signalling networks regulating
adipose tissue, metabolic homeostasis and the immune sys-
tem [2, 4]. Abnormal function in human Tribbles has been
implicated in a number of diseases including leukaemia,
metabolic syndromes and cardiovascular disease [9].
Mammalian Tribbles can interact with components of
the mitogen-activated protein (MAP) kinase pathway and
act as adaptor proteins to modulate the strength and out-
put of kinase signalling cascades [10–12]. Like fly Tribbles
[7, 13], mammalian Tribbles bind to the basic leucine
zipper (bZIP) transcription factors. Trib1 and Trib2 can
induce degradation of several CCAAT/enhancer-binding
protein (C/EBP) members in a context-dependent manner
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[1, 14, 15]. Trib3 binds to and inhibits the transcriptional
activity of both activating transcription factor 4 (ATF4)
and C/EBP homologous protein (CHOP) in cultured cell
lines [16–19], although the in vivo functional relevance of
such protein interactions remains unknown.
Given its extensive connections to different cellular
processes, many questions remain to be answered regarding
the role of Tribbles at the organismal level. No induction of
peptide after Drechmeria infection 3 (NIPI-3) is the single
Tribbles protein in Caenorhabditis elegans [20]. A role for
nipi-3 in the innate immune response was previously un-
covered through the isolation of a partial loss-of-function
mutation, which contains a missense mutation in the
pseudokinase domain [20]. NIPI-3 is required for the
upregulation of antimicrobial peptide (AMP) gene ex-
pression following infection by the fungus Drechmeria
coniospora [20]. It acts upstream of a p38 MAP kinase
(MAPK) pathway consisting of NSY-1/MAPKKK, SEK-
1/MAPKK and PMK-1/MAPK [20, 21]. Both NIPI-3
and all components of the MAPK cascade are required
cell autonomously in the epidermis during the immune
response [20].
In this study, we generated null mutations of nipi-3
and uncovered a novel role in animal development and
viability. The lethality of nipi-3 null animals is com-
pletely suppressed by loss of function in CEBP-1, a C.
elegans member of the C/EBP family, previously known
to be required for adult sensory axon regeneration and
neuronal stress responses [22, 23]. Unexpectedly, loss of
function in components of the PMK-1/p38 MAPK cascade
also suppresses the lethality of nipi-3 null animals. In nipi-3
mutants, the levels of activated PMK-1 are increased, in a
cebp-1-dependent manner. Through chromatin immuno-
precipitation and deep sequencing (ChIP-seq) analyses and
identification of target genes, we found that CEBP-1 binds
to a conserved DNA motif. Our analyses of candidate target
genes of CEBP-1 suggest a functional enrichment in devel-
opment and stress responses. Importantly, in contrast to its
role in innate immunity, we show that NIPI-3 acts in mul-
tiple tissues to negatively regulate transcriptional expression
of cebp-1. This inhibition of CEBP-1 by NIPI-3 is also re-
quired across multiple tissues to enable larval development
and maintain fecundity. The coordinated inhibition of
CEBP-1 by NIPI-3 in multiple tissues reveals novel re-
quirements for systemic regulation of signalling pathways
in organism development.
Results
C. elegans Tribbles nipi-3 is required for larval
development and viability
To better understand the biological roles of nipi-3, we
used clustered regularly interspaced short palindromic
repeats (CRISPR)-Cas9 genome editing [24–27] to gen-
erate two deletion alleles of nipi-3 (fr148 and ju1293)
and a green fluorescent protein (GFP) knock-in (KI)
(fr152) (Fig. 1a; see Methods and below). The fr148 and
ju1293 deletion alleles remove 1.6 kb and 0.6 kb of the
5′ region of the gene, respectively (Fig. 1a), resulting in
molecular nulls for nipi-3. The phenotypes of homozy-
gous mutants of either nipi-3 deletion allele, designated
as null (0), were indistinguishable (Fig. 1c, d). Mutants
arrested development at the second to third larval stages
(L2–L3) (see below) and eventually died between 5–10
days after hatching. When compared to wild-type larvae
at the same stage (2 days post-hatching), nipi-3(0)
arrested larvae displayed a small and dumpy body
morphology. At 3 days post-hatching, wild-type animals
reached the adult stage, as evidenced by fusion of seam
cells (lateral epidermal cells), formation of adult alae and
the vulva (Fig. 1b, f ). By contrast, all age-matched nipi-
3(0) animals were arrested at L2–L3, as the seam cells
did not fuse, adult alae were not observed and the vulval
invagination did not occur (Fig. 1c, d, f ). In these mutant
animals, the germline also appeared to be arrested, gen-
erally at L3 based on the size of the gonad and the num-
ber of germ cells (Fig. 1c, d, g). Occasionally, in nipi-3(0)
animals with longer bodies, we observed some sperm or
a few unfertilized oocytes. The nipi-3(0) animals also ex-
hibited an abnormal pharyngeal morphology (Additional
file 1: Figure S1). We rescued the larval lethality and
sterility of nipi-3(0) by expressing the wild-type nipi-3
genomic DNA as high-copy-number extrachromosomal
arrays (Fig. 1a, e, h; Methods). As expression from such
transgenes is silenced in the germline [28], this result
indicates that the larval lethality and germline develop-
ment defects of nipi-3(0) are both primarily due to its
function in somatic tissues. Thus, the analyses of nipi-3
null animals indicate an essential somatic role of nipi-3
in organism development.
Knocking-in gfp to the nipi-3 locus, which produced a
protein tagged at its N-terminus (GFP::NIPI-3), had no
adverse effect; KI animals (fr152) were fully viable and
indistinguishable from wild type in growth and move-
ment. We observed GFP expression in the epidermis,
intestine and in neurons (Fig. 1i), consistent with the
previously reported expression pattern obtained using
transgenic transcriptional reporters [20]. Interestingly,
although NIPI-3 does not have a clearly identifiable
nuclear-localization signal, GFP::NIPI-3 expression was
observed predominantly in the nuclei (Fig. 1i), with an
overall intensity peaking at the L2–L3 stages. This
nuclear localization suggests a role for NIPI-3 in regula-
tion of gene expression.
Loss of cebp-1 suppresses the lethality, but not the innate
immune response defect, of nipi-3 null animals
To dissect the molecular mechanisms involving NIPI-3, we
undertook a yeast two-hybrid screen using the full-length
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NIPI-3 protein as bait (Cypowyj S. et al., manuscript in
preparation). One prominent candidate interacting partner
was CEBP-1, a member of the C/EBP family of transcrip-
tion factors [22]. The CEBP-1 protein consists of 319 amino
acids, with a bZIP domain at its C-terminus. In further ana-
lyses using the yeast two-hybrid assay, we found that the
N-terminal region (amino acids 1–115) of CEBP-1 was suf-
ficient for binding NIPI-3 (Additional file 2: Figure S2). This
interaction is reminiscent of those observed for fly and ver-
tebrate Tribbles proteins, which bind and degrade C/EBP
family proteins [1, 7, 13–15, 29], with human Trib1 binding
the N-terminus of C/EBPα [1]. Thus, the ability of Tribbles
and C/EBP proteins to interact directly is likely conserved
from C. elegans to humans.
To understand the functional significance of the ob-
served protein interaction, we next performed genetic
analysis using null mutations of nipi-3 and cebp-1. Null
mutants of cebp-1 show normal development and body
appearance. Remarkably, cebp-1(0) completely suppressed
the growth and fertility defects of nipi-3(0) mutants
(Fig. 2b, h; Methods). cebp-1(0) also completely suppressed
the body size defect and the developmental delay observed
at 25 °C of the partial loss-of-function nipi-3(fr4) mutants
(Additional file 3: Figure S3). NIPI-3 is also known to be
Fig. 1 C. elegans Tribbles nipi-3 is required for larval development and viability. a The nipi-3 locus. Top, nipi-3 encodes a pseudokinase of the
Tribbles family. Middle, nipi-3 deletions generated using CRISPR-Cas9 genome editing. Bottom, the extent of the nipi-3 genomic region used to
rescue the deletion mutants. b–e Bright-field images of worms at 3 days post-hatching; wild type (b), nipi-3 null mutants (c,d) and a transgenic
animal (Tg) expressing the wild-type nipi-3 genomic DNA in a nipi-3(0) background (e). f Fluorescence images of worms expressing AJM-1::GFP
reporter in the epithelial cells to allow visualization of seam cells. g Overlaid differential interference contrast (DIC) and fluorescence image of a nipi-
3(fr148) mutant at 3 days post-hatching expressing lag-2p::GFP reporter. This image corresponds to the boxed region in d. Two distal tip cells (DTC) are
shown in green (arrow), and the germline of arrested nipi-3 null larva is denoted by a dotted red line. h Body length (μm) of worms at 3 days post-
hatching. Each dot represents a single animal measured as shown; each red line represents the mean value. ***P < 0.001; ns, not significant (one-way
ANOVA with Tukey’s post hoc tests). i Fluorescence images of endogenous NIPI-3 expression visualized in the GFP KI strain (fr152). Expression is
observed in the nuclei (yellow arrows) of the epidermis (left panel), the intestine (upper right panel) and the head neurons (lower right panel)
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Fig. 2 nipi-3(0) lethality is suppressed by loss of cebp-1 or components of a PMK-1/p38 MAPK cascade. a Schematic overview of the forward
genetic screen designed to identify the suppressors of nipi-3(0) larval arrest and lethality. b–g The mutations isolated from the nipi-3(0) suppressor
screen and the deletion null mutations tested for nipi-3(0) suppression assay are shown in the left column and bright-field images of worms at
3 days post-hatching are shown in the right column. h Body length (μm) of worms at 3 days post-hatching. Each dot represents a single animal
measured as shown; each red line represents the mean value; some data are replicated from Fig. 1 as shown with darker grey dots. ***P < 0.001;
ns, not significant (one-way ANOVA with Tukey’s post hoc tests)
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necessary for the epidermal innate immune response upon
fungal infection [20]. The expression of AMP genes after
fungal infection is highly induced in wild-type animals and
abrogated in nipi-3(fr4) mutants [20]. However, cebp-1(0)
nipi-3(0) animals did not exhibit an induction of the AMP
gene nlp-34 upon infection (Additional file 4: Figure S4a).
Further, cebp-1(0) nipi-3(0) animals expressing wild-type
cebp-1 in a tissue-specific manner in either the epider-
mis or neurons also showed no AMP gene induction
(Additional file 4: Figure S4a). These results indicate
that loss of cebp-1 does not suppress the immune re-
sponse defect in nipi-3(0). As cebp-1(0) strongly impairs
sensory axon regeneration after laser axotomy [22], we
also tested whether nipi-3 affected posterior lateral micro-
tubule (PLM) axon regeneration. Neither nipi-3(0) nor
nipi-3(fr4) showed significant effects in axon regeneration,
and cebp-1(0) nipi-3(0) double mutants showed impaired
axon regeneration similar to cebp-1(0) (Additional file 4:
Figure S4b). These results show that the genetic inter-
action between nipi-3 and cebp-1 is highly specific for lar-
val development and organism fecundity.
Loss of the PMK-1/p38 MAPK pathway also suppresses
nipi-3(0) lethality
To gain further insight into the mechanism underlying
nipi-3’s role in animal development, we performed a
forward genetic screen for suppressors of nipi-3(0) le-
thality. We mutagenized nipi-3(ju1293); Tg[nipi-3(+);
myo-2p::mCherry] animals (Methods). Among their F2
progeny, we isolated fertile animals that had lost the
rescuing transgene (Fig. 2a) and established multiple
suppressor lines (genotypes designated as nipi-3(0);
suppressor). We screened ~16,000 haploid genomes and
identified 7 independent suppressor alleles. All the identi-
fied suppressors in this study were associated with a full
reversion of the nipi-3(0) lethality; fertile adults could be
propagated without the nipi-3(+) rescuing transgene.
We characterized several suppressor mutations using
candidate gene analyses in combination with whole
genome sequencing. One suppressor caused a missense
mutation in the bZIP domain of cebp-1, and behaved
like cebp-1(0) (Fig. 2b, h). Among the other suppressors
of nipi-3(0), we found missense alterations in TIR-1/the
sterile alpha (SAM) and Toll-interleukin receptor (TIR)
motif-containing protein SARM), NSY-1/MAPKKK, SEK-
1/MAPKK and MAK-2/MAPK-activated protein kinase
(MAPKAPK) (Fig. 2c–f). These mutations are located in
known functional domains, including the TIR domain for
TIR-1, the kinase domains for NSY-1, SEK-1 and MAK-2,
and the DUF4071 domain, commonly found at the N-
terminus of many serine-threonine kinase-like proteins, for
NSY-1 (Fig. 2c–f). We then tested known null mutants in
each of these genes and found them to suppress nipi-3(0)
to the same degree as our suppressor mutations, as shown
by quantification of the body length (Fig. 2b–f, h; Add-
itional file 5: Figure S5a). Thus, loss of function in tir-1 and
these three kinase genes causes strong suppression of nipi-
3(0).
NIPI-3 has a specific role in the regulation of epider-
mal defense genes. It acts together with TIR-1, NSY-1
and SEK-1, as well as several other genes including tpa-1,
pmk-1 and sta-2 [20, 21, 30]. We therefore tested mutants
for these three latter genes for their genetic interaction
with nipi-3(0). We found that loss of pmk-1, but not tpa-1
or sta-2, suppressed the lethality of nipi-3(0) (Fig. 2 g, h
for pmk-1; Additional file 5: Figure S5b for tpa-1 and
sta-2). Loss of pmk-1 resulted in suppression of nipi-3(0)
phenotypes similar to the other suppressor mutants such
that nipi-3(0); pmk-1(0) double mutants developed into
fertile adults with adult alae and vulva. The rescue of body
size, however, was not complete (Fig. 2 g, h). As cebp-1 is
involved in two other MAPK cascades known for their
roles in adult axon regeneration [22, 31, 32], we tested
mutations in several other candidate genes and found that
loss of function in dlk-1, pmk-3, mlk-1 or kgb-1 did not
suppress nipi-3(0) defects (Additional file 5: Figure S5b).
Together, our analyses from both the forward genetic
screening and test of candidate mutants reveal a previ-
ously unknown role of CEBP-1 in larval development me-
diated by NIPI-3, and a novel genetic interaction between
NIPI-3 and the PMK-1/p38 MAPK cascade.
NIPI-3 inhibits PMK-1 phosphorylation via CEBP-1
To dissect the mechanism underlying the interaction be-
tween PMK-1/p38 MAPK and NIPI-3, we first asked how
the levels of active PMK-1 might be altered in nipi-3(0)
suppressor animals. We performed a Western blot analysis
using an anti-phospho-p38 MAPK antibody that specific-
ally recognizes phosphorylated, active PMK-1 [30]. We
made protein lysates from animals at 1 day post-hatching
(L2) because nipi-3(0) animals at this stage were as healthy
as the wild type. We observed that levels of active PMK-1
were significantly increased in nipi-3(0), but remained
similar to wild type in cebp-1(0) and cebp-1(0) nipi-3(0)
animals (Fig. 3a, b). Phosphorylated PMK-1 was undetect-
able in nipi-3(0) sek-1(0) animals, consistent with PMK-1
being activated by SEK-1 (Fig. 3a, b). The total PMK-1
levels were likely unchanged in nipi-3(0), as the mRNA
levels of pmk-1 were comparable between nipi-3(0) and
wild type when assessed by quantitative RT-PCR (Fig. 3c).
We note that mak-2(0) did not affect phosphorylated
PMK-1 (Additional file 6: Figure S6), suggesting that
MAK-2 likely acts downstream of, or in parallel to, PMK-1.
Together, these results suggest that the abnormally high
levels of phosphorylated PMK-1 in nipi-3(0) are dependent
on cebp-1.
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Fig. 3 NIPI-3 represses PMK-1 phosphorylation via cebp-1 and represses cebp-1 transcription. a Western blot analysis on total protein lysate from
various animal strains using the indicated antibodies, α-phospho-p38 MAPK antibody to detect a phosphorylated form of PMK-1 proteins (p-PMK-1)
or α-actin antibody as a loading control. b Densitometric quantifications of immunoblot signals normalized to actin. n = 3; error bars represent standard
error of the mean (SEM);
*** P < 0.001 (one-way ANOVA with Tukey’s post hoc tests). c Quantitative RT-PCR (qRT-PCR) analysis of pmk-1. Relative abundance of pmk-1
mRNA normalized to actin mRNA. n = 3; error bars represent SEM; ns, not significant (one-way ANOVA with Tukey’s post hoc tests). d–j Fluor-
escence images of cebp-1p::GFP reporter animals at L2. k qRT-PCR analysis of cebp-1 in WT, nipi-3(fr4), nipi-3(0) animals. Relative abundance of
cebp-1 mRNA normalized to actin mRNA. n = 3; error bars represent SEM; *P < 0.05; **P < 0.01; ns, not significant (one-way ANOVA with Tukey’s
post hoc tests). l, m Confocal fluorescence images (z-stack) of col-154p(epidermis)::CEBP-1::GFP reporter animals at L2. n Quantification of GFP inten-
sity measured in each epidermal nucleus (10 per animal). n = 6; error bars represent SEM; ns, not significant (Student’s unpaired t test). Primary
data for panels (b, c, and k) are provided in Additional file 14
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NIPI-3 represses the transcription of cebp-1 in multiple
tissues
To dissect how NIPI-3 inhibits CEBP-1, we examined
whether cebp-1 levels were altered in nipi-3(0) and in
each nipi-3(0) suppressor. Transcriptional reporters of
cebp-1 (Tg[cebp-1p::GFP]) were broadly expressed in most
post-embryonic tissues, including epidermis, muscles,
pharynx, intestine and neurons (Fig. 3d–j). Strikingly, the
expression of the cebp-1 transcriptional reporter was
highly and significantly increased in both nipi-3(fr4) and
nipi-3(0) mutants, compared with wild-type animals
(Fig. 3d–f ). Quantitative RT-PCR analysis also showed sig-
nificantly increased expression of cebp-1 mRNAs in nipi-3
mutant animals (Fig. 3 k). Consistent with the observed
transcriptional regulation, we found that a translational
CEBP-1::GFP reporter driven by a heterologous epidermal
promoter showed no detectable differences in GFP expres-
sion in a nipi-3(0) background (Fig. 3 l–n). The increased
expression of cebp-1p::GFP in nipi-3(0) was reduced to
normal levels when a nipi-3(+) transgene was introduced
(Fig. 3 g), indicating that NIPI-3 represses the transcrip-
tion of cebp-1. Additionally, the transcriptional repression
of cebp-1 by NIPI-3 was largely independent of the PMK-1
pathway since cebp-1p::GFP expression in nipi-3(0)
remained high in animals that also carried a null mutation
of nsy-1, pmk-1 or mak-2 (Fig. 3 h–j). Together, the results
show that NIPI-3 negatively regulates expression of cebp-1
at the transcriptional level and that CEBP-1 acts upstream
of the PMK-1 pathway.
The tight regulation of cebp-1’s expression level is crit-
ical for animal viability. We found that suppression of
nipi-3(0) by cebp-1(0) was semi-dominant, as cebp-1(0)/+
caused partial but significant suppression of the short body
length of nipi-3(0) mutants (Additional file 7: Figure S7).
Moreover, in a wild-type background, the transgene eft-
3p::CEBP-1::GFP, which drives strong and ubiquitous
expression of CEBP-1, caused dose-dependent lethality
(see Methods). In addition, expression of a full-length
functional translational reporter of cebp-1 (cebp-1p::CEBP-
1::GFP) in nipi-3(0) mutant animals exacerbated develop-
mental defects and accelerated larval lethality, while the
same transgene showed no such effects in a wild-type
background. Together, these results support the conclu-
sion that the lethality observed in nipi-3(0) mutants is a
direct consequence of cebp-1 overexpression.
Overexpression of truncated forms of CEBP-1 suppresses
nipi-3(0) lethality
To dissect the molecular basis of CEBP-1’s role in animal
development, we expressed truncated forms of CEBP-1
lacking the bZIP domain (amino acids 1–230 or 1–115),
or lacking the N-terminus (amino acids 237–319) in nipi-
3(0) mutants. Surprisingly, in stark contrast to the strong
lethality caused by overexpressing full-length CEBP-1 in
nipi-3(0) mutants, we found that expression of either the
N-terminal fragment or the bZIP domain of CEBP-1 alone
resulted in significant suppression of nipi-3(0) defects
(Fig. 4a–d). Overexpression of either the N- or C-terminal
truncated protein caused no defects either in the wild-type
or cebp-1(0) backgrounds. Among the three CEBP-1 frag-
ments, the expression of C-terminal CEBP-1 (amino acids
237–319) showed the most effective rescue, judged by the
fecundity of the transgenic lines and quantitative com-
parisons of body length (Fig. 4c, d). The expression
levels of CEBP-1(amino acids 1–230)::GFP were markedly
increased in nipi-3(0), presumably reflecting the transcrip-
tional regulation of cebp-1 described above. We noticed
the fluorescence intensity was most strongly increased in
the epidermis and neurons, throughout the head region
and in the ventral nerve cords (Fig. 4e–g). These observa-
tions suggest that the truncated forms of CEBP-1 act in a
dominant negative manner to inhibit the activity of the
endogenous CEBP-1.
CEBP-1 binds conserved DNA motifs in genes regulating
development and stress response
To gain further insight into CEBP-1’s function in animal
development, we next sought candidate target genes of
CEBP-1 by performing ChIP-seq analysis on transgenic
animals expressing a functional FLAG-tagged CEBP-1
protein in a cebp-1(0) background (Methods). We found
209 CEBP-1 ChIP-seq peaks in the genome that were as-
sociated with 212 coding genes (Additional file 8: Table
S1). CEBP-1 peaks were preferentially located within the
promoter regions of the target genes (169 genes, 79 %),
less frequently within introns (43 genes, 21 %) and never
within exons.
We then performed motif analysis of the genomic re-
gions bound by CEBP-1 using the motif discovery tools
Multiple Em for Motif Elicitation (MEME) [33] and
Regulatory Sequence Analysis Tools (RSAT) [34]. The
most over-represented motif, NTTDYGAAAH, was found
in 139 out of 209 CEBP-1 ChIP-seq peak regions (Fig. 5a).
We then compared this motif with published motifs using
the motif comparison tool Tomtom [35] and found the
most statistically significant similarities to vertebrate C/
EBP binding motifs [36]. The conservation of CEBP-1
binding motif further reinforces the functional parallels
between C. elegans CEBP-1 and vertebrate C/EBPs.
As CEBP-1 likely acts upstream of the PMK-1 pathway,
we searched among the targets of CEBP-1 for components
of the PMK-1 pathway and found CEBP-1 ChIP-seq peaks
present in the promoter of sek-1 (Additional file 9: Figure
S8). When we examined the mRNA levels of sek-1 by
quantitative RT-PCR in nipi-3(0) animals where cebp-1 is
overexpressed, we observed increased sek-1 mRNA levels
(Fig. 5b). In contrast, in nipi-3(0) cebp-1(0) animals the
levels of sek-1 mRNAs were similar to those of the wild
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Fig. 5 CEBP-1 binds conserved DNA motifs in genes regulating development and stress response. a Motif logo of the most over-represented
motif among CEBP-1 ChIP-seq peaks. b qRT-PCR analysis of sek-1. Relative abundance of pmk-1 mRNA normalized to actin mRNA. n = 3; error bars
represent SEM; *P < 0.05; ns, not significant (one-way ANOVA with Tukey’s post hoc tests). Primary data are provided in Additional file 14. c Hierarchical
clustering of genes and functional classes (see Additional file 10: Figure S9 and Additional file 8: Table S1 for class labels and full data); the presence of
a gene in a class is represented by a red rectangle, its absence by blue
Fig. 4 Overexpression of truncated forms of CEBP-1 protein suppresses nipi-3(0) lethality. a–c Bright-field images of worms at 3 days post-hatching
expressing truncated forms of CEBP-1 proteins. d Body length (μm) of worms at 3 days post-hatching. Each dot represents a single animal measured
as shown; each red line represents the mean value; some data are replicated from Fig. 1 as shown with darker grey dots. ***P < 0.001; ns, not significant
(one-way ANOVA with Tukey’s post hoc tests). e, f Confocal fluorescence images (z-stack) of cebp-1p::CEBP-1(aa 1-230)::GFP reporter animals at L2.
g Quantification of GFP intensity measured in the region of head neurons. Error bars represent SEM; ***P < 0.001 (Student’s unpaired t test)
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type. These results suggest that the abnormally high levels
of cebp-1 in nipi-3(0) can promote the expression of sek-1,
which in turn promotes the phosphorylation of PMK-1
[30], leading to abnormal larval development and lethality.
We then asked whether the list of potential CEBP-1
targets was enriched for genes with specific functions.
To this end, we searched for enriched categories through
an Expression Analysis Systematic Explorer (EASE) ana-
lysis [37, 38], using our in-house database of functional
annotations as described [39]. This includes 4600 datasets
automatically updated from multiple sources including
WormBase, FlyBase, the Kyoto Encyclopedia of Genes and
Genomes (KEGG) and relevant RNAi databases. Most
(80 %) of CEBP-1 target genes were associated with at
least one of 33 enriched functional classes (P < 10-5;
Additional file 8: Table S1). Hierarchical clustering of
the genes in each of the enriched classes identified two
main groups (Fig. 5c; Additional file 10: Figure S9;
Additional file 8: Table S1). One group is related to de-
velopment with phenotypic classes such as 'larval lethal’
or 'slow growth’ and includes genes involved in basic cellu-
lar processes, transcription, translation or endocytosis.
The second group is related to the response to biotic or
abiotic stress, including response to cadmium, hygromycin
or bacterial toxins. Interestingly, McEwan et al. have found
that most of the genes upregulated in nipi-3(fr4) mutants
are also induced by the translational inhibitory toxin
ToxA. Out of the 14 stress-related classes associated with
the cebp-1 targets, 10 are shared with those found for
genes upregulated in nipi-3(fr4) (D.L. McEwan, personal
communication; P < 10-10; Additional file 8: Table S1). On
the other hand, consistent with the fact that the nipi-3(fr4)
allele does not provoke larval lethality, only 1 out of the 10
classes in the development cluster is shared between the
cebp-1 targets and the genes upregulated in nipi-3(fr4).
These analyses suggest that CEBP-1 regulates genes func-
tioning in development and in stress responses, and might
have a particularly important impact on organismal physi-
ology when overexpressed in a nipi-3 mutant context.
NIPI-3 is required in multiple tissues to ensure proper
larval development
We next asked in which tissue the expression of nipi-3(+)
is required for animal viability. We expressed nipi-3(+) in
a tissue-specific manner, using intestinal, epidermal and
pan-neuronal promoters, in the nipi-3(0) background
(Fig. 6a–f ). In contrast to the complete rescue of body size
and lethality in nipi-3(0) mutants expressing nipi-3(+)
under its own promoter (Fig. 1e, h), expressing nipi-3(+)
in individual tissues failed to rescue the developmental
arrest (Fig. 6a–c, f). Pan-neuronal expression of nipi-3(+)
resulted in slightly increased body length of nipi-3(0)
3 days post-hatching (Fig. 6c, f ). Since nipi-3 activity
strongly inhibits cebp-1 transcription in the epidermis and
neurons (Fig. 4e–g), we expressed nipi-3(+) in both of
these tissues together, and found that these transgenic ani-
mals showed an increased body size (Fig. 6e, f ), compared
to those expressing nipi-3(+) in each tissue alone, or in the
intestine and epidermis simultaneously (Fig. 6a–d, f).
Some of the transgenic animals with a body length closer
to that of wild-type animals showed improved somatic
and germline development, with formation of vulva and
adult alae, and produced a few viable but infertile progeny.
When we expressed nipi-3(+) in all three tissues together,
the transgenic animals showed no further improvement of
body size compared to those expressing nipi-3(+) in both
the epidermis and neurons (Fig. 6f), and did not recapitu-
late the rescue of lethality associated with the expression
of nipi-3 under its own promoter. Thus, we conclude that
NIPI-3 is required in multiple tissues, particularly epider-
mis and neurons, for animal growth and development.
Suppression of nipi-3(0) by cebp-1(0) also requires a block
of CEBP-1 activity in multiple tissues
Conversely, we asked whether expression of cebp-1(+) in
a single tissue might cause the viable nipi-3(0) cebp-1(0)
animals to die. We expressed cebp-1(+) using the intestinal,
epidermal and pan-neuronal promoters in cebp-1(0) nipi-
3(0) double mutants (Fig. 6 g). Expression of cebp-1(+) in
individual tissues was insufficient to produce larval lethal
phenotypes in cebp-1(0) nipi-3(0) animals. Interestingly,
epidermal or neuronal expression of cebp-1(+) in cebp-1(0)
nipi-3(0) double mutants caused short body length, but not
in cebp-1(0) mutants (Fig. 6 g). Co-expression of cebp-1(+)
in the epidermis and neurons resulted in further reductions
in body length, although these were not as severe as those
in nipi-3(0) animals (Fig. 6 g). In addition, we noticed that
the same transgenes expressing cebp-1(+) in both epidermis
and neurons caused an abnormal pharyngeal morphology
in cebp-1(0) nipi-3(0) animals, similar to that seen in nipi-
3(0) mutants (Additional file 1: Figure S1). Together, our
data suggest that the tight regulation of both NIPI-3 and
CEBP-1 in multiple tissues is required in a systemic manner
for normal animal growth and development.
Discussion
C. elegans Tribbles NIPI-3 was identified on the basis of
its roles in host defense [20, 21]. Here, through generation
and analyses of null alleles, we find nipi-3 to be essential
for animal development and viability. Remarkably, the lar-
val arrest and lethality caused by complete loss of nipi-3 is
fully suppressed by loss of cebp-1, a C/EBP bZIP transcrip-
tion factor, or by loss of function in the PMK-1/p38
MAPK cascade including tir-1/SARM, nsy-1/MAPKKK,
sek-1/MAPKK and pmk-1/MAPK. Our data show that
complete elimination of the function of nipi-3 causes
abnormally high expression of CEBP-1, and activation
of PMK-1 MAPK. This then disrupts development and
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leads to death. The level of sek-1 mRNA is increased in
nipi-3(0) mutants but not in cebp-1(0) or in nipi-3
cebp-1 animals. The level of phosphorylated (active)
PMK-1 follows the same trend. Coupled with our ChIP-
seq analyses and genetic epistasis data, this suggests that
CEBP-1 acts as a direct positive regulator of sek-1. The
PMK-1 pathway is therefore activated when CEBP-1 ex-
pression is high in nipi-3(0). On the other hand, cebp-1 ex-
pression levels remain high in nipi-3(0); pmk-1(0) animals,
confirming that CEBP-1 does not act downstream of the
PMK-1 pathway. Together, these results suggest that
NIPI-3 negatively regulates the PMK-1 MAPK cascade, via
CEBP-1, to promote animal viability and development
(Fig. 6 h).
In innate immunity, however, nipi-3 cell-autonomously
promotes or enhances the same p38 kinase cascade to ac-
tivate host defense in the epidermis [20]. It has been
shown that overexpression of sek-1 in the epidermis res-
cues the block of AMP induction in nipi-3 mutants upon
fungal infection [20], and an overexpression of nipi-3 pro-
vokes an increase in the constitutive expression of AMP
which is dependent on the p38 cascade [21]. It is
Fig. 6 Tight regulation of both NIPI-3 and CEBP-1 is required in multiple tissues for proper organism development. a–e Bright-field images and (f)
the body length of worms expressing tissue-specific nipi-3(+) driven by the intestinal (mtl-2), epidermal (col-12) or pan-neuronal (rgef-1) promoters
in a nipi-3(0) background. g The body length of worms expressing tissue-specific cebp-1(+) driven by the intestinal (ges-1), epidermal (col-154) or
pan-neuronal (rgef-1) promoters in a nipi-3(0) cebp-1(0) background. f, g Each dot represents a single animal measured as shown; each red line
represents the mean value; some data are replicated from Figs. 1 and 2 as shown with darker grey dots. **P < 0.01; ***P < 0.001; ns, not significant
(one-way ANOVA with Tukey’s post hoc tests). h Working model for NIPI-3 function in C. elegans development. In wild type, presence of NIPI-3
keeps cebp-1 expression level optimal for coordinated tissue development. In nipi-3(0), however, cebp-1 and sek-1 are overexpressed and in turn
PMK-1 is hyperactivated
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intriguing that NIPI-3 appears to be capable of activating
or inhibiting PMK-1/p38 in the epidermis at different
times or under different conditions (infection versus de-
velopment). How might NIPI-3 achieve this dual role
under different stresses and in altered cellular contexts?
As Tribbles proteins are well known to act as adaptors,
NIPI-3 might be regulated via binding with other co-
factors only present under specific circumstances. Indeed,
we find that other upstream and downstream components
of the epidermal immune response cascade are not in-
volved in the developmental regulation described here.
Thus, the core PMK-1/p38 MAPK cassette has evolved
context-specific functions depending on different up-
stream regulators or co-factors [40, 41]. Members of the
Tribbles family in other species have been mostly studied
in the context of cell proliferation, adipocyte tissue differ-
entiation, energy metabolism and immunity, where they
function in a cell-autonomous manner. Our discovery of
the opposing roles of NIPI-3 in development and in the
immune response illustrates how cellular context can alter
the function of highly conserved signalling molecules.
Negative regulation of C/EBP by Tribbles has been ob-
served throughout the animal kingdom. Drosophila and
mammalian Tribbles bind and degrade C/EBP proteins
[1, 7, 13–15]. We find that C. elegans NIPI-3 represses
the transcription of cebp-1, which has important func-
tional consequences in vivo. This form of regulation has
not been reported in other organisms. Given its nuclear
localization, NIPI-3 may inhibit the transcription of
cebp-1 by interfering with other transcription factor(s).
The promoter of cebp-1 contains putative CEBP-1 bind-
ing consensus motifs, raising the possibility that NIPI-3,
by binding to CEBP-1, may also alter the transcriptional
activity of CEBP-1.
NIPI-3 is required to control CEBP-1 levels in multiple
tissues for animal development and viability. Consistent
with the inhibition of CEBP-1 expression by NIPI-3 in
the epidermis and neurons, simultaneous expression of
nipi-3(+) in both tissues makes a noticeable contribution
to animal development in nipi-3(0) mutants, compared
with nipi-3(+) expression in single tissues. Conversely,
simultaneous expression of cebp-1(+) in both epidermis
and neurons causes noticeable defects in animal develop-
ment in nipi-3(0) cebp-1(0) mutants, compared with cebp-
1(+) expression in single tissues. Thus, a tightly regulated
coordination of these two genes’ interactions in multiple
tissues is required to ensure proper development.
A key conclusion from our study is that the precise con-
trol of CEBP-1 and PMK-1/p38 MAPK pathways in mul-
tiple tissues is critical for organismal development. NIPI-3
acts as a master regulator to prevent improper activation
of CEBP-1 and PMK-1, whose hyperactivation during
development has deleterious consequences. Interestingly,
hyperactivation of PMK-1/p38 was previously shown to
block larval development when the endoplasmic reticulum
unfolded protein response was altered [42]. Moreover, in-
nate immune activation with a xenobiotic that provides
protection from bacterial infection in the adult has been
shown to provoke a growth delay during development
[43]. Subsequently, an elegant genetic suppressor screen
revealed that mutations in the PMK-1/p38 MAPK path-
way suppressed this developmental phenotype [44]. Thus,
the NIPI-3/CEBP-1 axis is a key mechanism by which
immune effector expression is held in check during
nematode development.
During normal development, both CEBP-1 and PMK-1
are maintained at a basal level by NIPI-3. The levels of
inducible signalling from these pathways are, however,
important for animals to protect themselves or to promote
repair. For instance, following fungal infection, NIPI-3
promotes the PMK-1/p38 MAPK signalling pathway in
the epidermis [20]. Thus, animals can successfully defend
themselves from fungal infection with activated PMK-1
locally in the epidermis, while survival is not affected
as PMK-1 remains inactive in other tissues. Similarly,
CEBP-1 is known to play a key role in neuronal stress
responses [22, 23, 45], and we identified potential CEBP-1
target genes that are involved in different stress responses.
Moreover, a concomitant study has identified NIPI-3 as a
negative regulator of CEBP-1 in intestinal defense against
the bacterial toxin ToxA (McEwan et al., personal com-
munication). An important challenge for the future will
be to understand how NIPI-3 regulates its downstream
pathways and how NIPI-3 itself is regulated depending
on developmental and environmental conditions. Un-
derstanding the molecular mechanism of this systemic,
coordinated regulation should advance our knowledge
of how animal development can be maintained in the
face of environmental stresses.
Conclusions
We showed a novel essential role for the C. elegans Tribbles
homolog NIPI-3 in animal development and viability,
which requires NIPI-3’s function in multiple tissues. NIPI-3
acts as a master regulator to prevent improper activation of
a C/EBP transcription factor and a conserved PMK-1/p38
MAPK signalling cascade known to control innate immun-
ity. These findings suggest that innate immune responses
are tightly controlled for proper organismal development.
Methods
Strains, transgenes and plasmids
C. elegans strains were maintained under standard con-
ditions at 20 °C unless otherwise mentioned. The wild
type was the N2 Bristol strain [46]. New strains were
constructed using standard procedures, and all geno-
types were confirmed by PCR or sequencing. All strains
and their genotypes used in this study are described in
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Additional file 11: Table S2. Extrachromosomal array
transgenic lines were generated as described previously
[47]. Expression constructs, transgenes and strain geno-
types are also summarized in Additional file 11: Table
S2. For all experiments, at least two independent trans-
genic lines were examined and quantitative data are
shown for one. In our studies of cebp-1 dosage effect,
we could not generate transgenic animals when inject-
ing 10 ng/μl of eft-3p::CEBP-1::GFP transgenes into
wild-type animals, while many transgenic lines were ob-
tained when cebp-1::gfp DNA was injected with lower
concentrations (i.e. 1 ng/μl or 0.01 ng/μl). All plasmids
used in this study are described in Additional file 12:
Table S3a.
CRISPR-Cas9-mediated deletion and GFP KI
We generated the nipi-3(ju1293) deletion allele using the
co-CRISPR method [25, 48]. We used four single guide
RNAs (sgRNAs) targeting the N-terminus of the nipi-3
gene (Additional file 12: Table S3a). U6p::nipi-3 sgRNAs
were generated by Gibson assembly and injected into
cebp-1(tm2807) worms, using standard methods, in mix-
tures composed of 30 ng/μl of each nipi-3 sgRNA, 50 ng/
μl of eft-3p::Cas9-SV40NLS::tbb-2 3′UTR, 50 ng/μl of
U6p::unc-22 sgRNA and 1.5 ng/μl of myo-2p::mCherry.
For the nipi-3(fr148) deletion allele, a single sgRNA target-
ing the N-terminus of the nipi-3 gene (Additional file 12:
Table S3a) was injected into cebp-1(tm2807) worms, in
mixtures composed of 50 ng/μl of nipi-3 sgRNA, 30 ng/μl
of eft-3p::Cas9-SV40NLS::tbb-2 3′UTR and 30 ng/μl of
col-12p::dsRed [49]. Note that we also injected many wild-
type worms with various combinations of nipi-3 sgRNAs,
but failed to isolate any deletion alleles.
GFP KI in the nipi-3 locus, nipi-3(fr152) was generated
with the same mixture as for nipi-3(fr148), providing
30 ng/μl of the nipi-3 repair template pSO1. This template
was generated by Gibson assembly in the self-excising
(SEC) cassette containing vector pDD282 [50] with 716 bp
and 518 bp homology arms upstream and downstream of
the nipi-3 start codon, respectively (Additional file 12:
Table S3a).
Genetic screen for nipi-3(0) lethality suppressors
nipi-3(ju1293) mutant animals carrying juEx6807[nipi-3
genomic DNA; myo-2p::mCherry] were mutagenized using
45 mM ethyl methane sulphonate (EMS) following stand-
ard procedures as described [46]. Animals were distrib-
uted onto nematode growth media (NGM) plates seeded
with Escherichia coli OP50 and screened in the F2 gener-
ation for normal animal growth reaching adulthood with-
out expressing the transgene (no pharyngeal mCherry)
under a fluorescence dissecting microscope.
Mapping and cloning of nipi-3 suppressor alleles
We first performed a conventional Sanger sequencing
analysis for all suppressor alleles for cebp-1 and determined
that the ju1367 allele affected cebp-1. We next sequenced
mak-2, which was previously known to act in the same
pathway as cebp-1 in neurons [22], and found ju1349 and
ju1352 alleles to affect mak-2. All other suppressors were
analysed by whole genome sequencing analysis and single-
nucleotide polymorphism (SNP) mapping following estab-
lished methods [51]. Briefly, genomic DNA was prepared
using a Puregene Cell and Tissue Kit (Qiagen) according to
the manufacturer’s instructions, and 20X coverage of se-
quences was obtained using a 90 bp paired-end Illumina
HiSeq 2000 at Beijing Genomics Institute (BGI Americas).
The raw sequences were mapped to the C. elegans ref-
erence genome (WS220/ce10) using Burrows-Wheeler
Aligner (BWA) [52] in the Galaxy platform (http://use-
galaxy.org) [53]. Following subtraction of the nucleo-
tide variants in the original strains, we generated a list
of candidate genes containing unique homozygous nu-
cleotide variants that were predicated to alter the func-
tion of the gene. We then confirmed the causality of
the candidate genes by testing the known null alleles
on the suppression of nipi-3(0).
Body length analysis
To examine the body length of animals during develop-
ment, we obtained synchronized animals. Briefly, 5–15
gravid adults were placed on a seeded NGM plate to
allow egg-laying for 3 h. Eggs laid during this period
were incubated at 20 °C for 72 h, and the animals were
then mounted on 2 % agarose pads containing a drop of
2.5 mM levamisole and photographed with a Zeiss Axio-
plan compound microscope, using Nomarski-DIC optics
and an attached AxioCam digital camera. ImageJ software
(National Institutes of Health (NIH), Bethesda, MD, USA)
was used to measure body length by drawing a freehand
midline from the tip of the nose to the tip of the tail of
each animal.
Western blot analysis
Worms of each genotype (80–100 individuals of L2 stage
worms) were collected and washed with M9 buffer and
boiled in sodium dodecyl sulphate (SDS) sample buffer
for 10 min and loaded onto SDS-polyacrylamide gel
electrophoresis (PAGE) gel (Bio-Rad). A 1:500 dilution of
rabbit anti-phospho-p38 MAPK (Cell Signaling, #9211)
and a 1:10,000 dilution of mouse anti-actin (MPbio,
#08691001) were used as primary antibodies. ImageJ was
used to quantify the intensity of the immunoblot bands.
Quantitative RT-PCR
Quantitative real-time PCR was performed as previ-
ously described [49]. Sequences of primers are given
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in Additional file 12: Table S3b. To collect synchro-
nized nipi-3(0) homozygous animals, we maintained
nipi-3(0) animals on cebp-1 RNAi plates. Gravid adults
were then treated by bleaching solution to collect
nipi-3(0) embryos, which were placed directly on regu-
lar NGM plates for 2 days in parallel to other strains.
Fluorescence microscopy and axon regeneration by laser
axotomy
Animals were mounted on 2 % agarose pads and immo-
bilized with 2.5 mM levamisole. For transcriptional
cebp-1p::GFP, GFP expression was imaged with a Zeiss
Axioplan compound microscope, using Nomarski optics
and an attached AxioCam digital camera. Translational
CEBP-1::GFP expression was imaged with a Zeiss LSM710
confocal microscope for quantitative analyses. For confocal
images, z stacks were obtained and maximum projection
images were created using Zeiss Zen 2012 software. ImageJ
was used to measure the GFP intensity at the nerve ring
area for cebp-1p::CEBP-1::GFP and at each nucleus (10 per
animal) for col-154p::CEBP-1::GFP. GFP::NIPI-3 KI expres-
sion was imaged with a spinning disk confocal microscope
as described [54] to improve the signal-to-noise ratio.
We cut PLM axons and quantified the length of re-
grown axons as described [55].
CEBP-1 ChIP-seq analysis
We generated transgenic animals expressing a functional
FLAG-tagged CEBP-1 protein in a cebp-1(tm2807) mu-
tant background (cebp-1(0); juIs418 [cebp-1p::FLAG::-
CEBP-1::cebp-1 3′UTR]) (Additional file 13: Figure S10)
and then immunoprecipitated FLAG-CEBP-1-associated
DNA fragments using anti-FLAG antibodies (M2 anti-
FLAG magnetic beads; Sigma). We collected mixed stage
worms grown at 20 °C on NGM plates followed by 2 %
formaldehyde and sonicated the samples as described
[56]. We next generated ChIP-seq DNA libraries via li-
gating DNA to specific adaptors and amplification with
barcode primers, then sequenced them on the Illumina
HiSeq 2000 platform. We performed two independent
ChIP-seq experiments with parallel genomic DNA con-
trols prepared from the same strain. We conducted peak
calling using a CLC Genomics Workbench 6.0 (CLC
bio). To define genes associated with the peaks, we used
the annotation of transcription start site (TSS) and tran-
scription end site (TES) from Wormbase WS220 (http://
www.wormbase.org) and annotated the peak if it over-
lapped with the gene or the 3 kb upstream of the TSS.
We then manually confirmed the peaks and associated
genes using the University of California, Santa Cruz
(UCSC) browser and an update to WS252. If the peak
was found within the promoter for one isoform and in-
trons for other isoforms, we categorized it as a peak
within a promoter. The ChIP-seq data are available at
the Gene Expression Omnibus [GEO:GSE83330].
Bioinformatic analyses
MEME [33] and RSAT [34] were used to identify over-
represented motifs from 209 CEBP-1 ChIP-seq peak se-
quences, and then Tomtom [35] was used to compare
the most over-represented motif against a database of
known motifs in vertebrates. All informatics tools can be
found at http://meme-suite.org and http://www.rsat.eu.
Enrichment analyses were run on a newly developed
database of functional annotations including 4600 data-
sets [39] updated to Wormbase WS252 (http://
www.wormbase.org). Classes considered for enrichment
had a maximum size of 2000 genes, and the P value for
enrichment was lower than 10-5.
Yeast two-hybrid assay
Full-length or fragments of complementary DNAs (cDNAs)
were cloned into the pACT2 (Gal4 activation domain) or
pBTM116 (LexA DNA-binding domain) vectors (Clontech)
and constructs were co-transformed into yeast strain L40.
We grew transformed yeasts on agar plates with synthetic
defined (SD) minimal medium lacking leucine and tryp-
tophan; interactions were examined on plates with SD
medium lacking leucine, tryptophan and histidine.
Statistical analysis
Statistical analysis was performed using GraphPad Prism
5. Significance was determined using unpaired t tests for
two samples, one-way ANOVA followed by Tukey’s mul-
tiple comparison tests for multiple samples. For two nom-
inal variables, Fisher’s exact test was used to evaluate the
statistical significance. P < 0.05 (*) was considered statisti-
cally significant (* P < 0.05; ** P < 0.01; *** P < 0.001).
Additional files
Additional file 1: Figure S1. CEBP-1 expression in multiple tissues causes
an abnormal pharyngeal morphology in nipi-3(0) cebp-1(0) animals. (a)
Differential interference contrast (DIC) images of worms at 3 days post-
hatching. Pharynx and intestine are denoted by a dotted red and yellow
line, respectively. (b) Co-expression of cebp-1(+) in the epidermis and
neurons in nipi-3(0) cebp-1(0) animals caused pharyngeal morphology
defect. *P < 0.05; **P < 0.01; ns, not significant (two-tailed Fisher’s exact
test). (PDF 3776 kb)
Additional file 2: Figure S2. NIPI-3 interacts with CEBP-1 in yeast
two-hybrid assay. CEBP-1 variants were fused to the Gal4 activation domain
and tested for their interaction with full-length NIPI-3 fused to the LexA
DNA-binding domain. A large CEBP-1 fragment (Δ2, amino acids 1–115) was
sufficient for the NIPI-3 interaction. – refers to no growth and + refers to
growth in the absence of histidine. (PDF 433 kb)
Additional file 3: Figure S3. Loss of cebp-1 rescues the nipi-3(fr4)
phenotype. (a) Bright-field images and (b) body length of worms at 3 days
post-hatching grown at 25 °C. (b) Each dot represents a single animal
measured as shown; each red line represents the mean value. ***P< 0.001; ns,
not significant (one-way ANOVA with Tukey’s post hoc tests). (PDF 1253 kb)
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Additional file 4: Figure S4. cebp-1 and nipi-3 are dispensable in
immune response and axon regeneration, respectively. (a) qRT-PCR analysis
of AMP gene, nlp-34. Relative abundance of nlp-34 mRNA normalized to
actin mRNA. n = 3. Error bars represent SEM. ***P < 0.001; ns, not significant
(one-way ANOVA with Tukey’s post hoc tests). Primary data are provided in
Additional file 14. (b) Axotomy and axon regeneration analysis. Normalized
PLM axon regrowth is shown in the bar graph. Error bars represent
SEM. ***P < 0.001; ns, not significant (one-way ANOVA with Tukey’s post
hoc tests). (PDF 472 kb)
Additional file 5: Figure S5. Quantification of the body length of
suppressor alleles identified from the screen and loss-of-function mutants
of tpa-1, pmk-1, sta-2, dlk-1, pmk-3, mlk-1 and kgb-1. (a, b) Body length of
worms at 3 days post-hatching. Each dot represents a single animal
measured as shown; each red line represents the mean value; some
data are replicated from Fig. 1 as shown with darker grey dots. ***P < 0.001
(one-way ANOVA with Tukey’s post hoc tests). (PDF 569 kb)
Additional file 6: Figure S6. Phosphorylated PMK-1 levels are unchanged
in nipi-3(0); mak-2(0) animals. (a) Western blot analysis on total protein lysate
from various animal strains using the indicated antibodies, α-phospho-p38
MAPK antibody to detect a phosphorylated form of PMK-1 proteins (p-PMK-1)
or α-actin antibody as a loading control. (b) Densitometric quantifications of
immunoblot signals normalized to actin. n = 4; error bars represent SEM; ns,
not significant (Student’s paired t test). Primary data are provided in Additional
file 14. (PDF 595 kb)
Additional file 7: Figure S7. cebp-1 shows a dosage sensitive effect in
nipi-3(0) mutants. (a) Bright-field images and (b) body length of worms at
3 days post-hatching. (b) Each dot represents a single animal measured
as shown; each red line represents the mean value. ***P < 0.001 (one-way
ANOVA with Tukey’s post hoc tests). (PDF 1501 kb)
Additional file 8: Table S1. List of CEBP-1 target genes and hierarchical
clustering of genes and functional classes (XLSX 64 kb)
Additional file 9: Figure S8. The promoter of sek-1 contains a ChIP-seq
peak of CEBP-1. The promoter region of sek-1 contains two consensus
DNA-binding motifs for CEBP-1 (black triangles). Top, the sek-1 locus. Middle,
sequencing reads from CEBP-1-IP. Bottom, sequencing reads from genomic
DNA input. (PDF 253 kb)
Additional file 10: Figure S9. Hierarchical clustering of genes and
functional classes. The presence of a gene in a class is represented by a
red rectangle, its absence in blue. See Additional file 8: Table S1 for class
labels and full data. (PDF 680 kb)
Additional file 11: Table S2. List of strains and alleles. (XLSX 18 kb)
Additional file 12: Table S3. List of plasmids and primers used for
qRT-PCR. (XLSX 13 kb)
Additional file 13: Figure S10. FLAG-tagged CEBP-1 protein rescues
PLM axon regeneration defects of cebp-1(0). Axotomy and axon regener-
ation analysis. Normalized PLM axon regrowth is shown in the bar graph.
Error bars represent SEM. ***P < 0.001; ns, not significant (one-way ANOVA
with Tukey’s post hoc tests). (PDF 432 kb)
Additional file 14: Primary data for Figs. 3b, c, k and 5b and Figures S4a
and S6b. (XLSX 20 kb)
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